The management of fatigue in cancer patients

ONCOLOGY

Volumn 18, Issue 12, 2004, Pages 1527-1534

  Lawrence, Donald R ^a   Lipman, Andrew J ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ERYTHROPOIETIN; NEUROLEPTIC AGENT;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COUNSELING; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DRUG ADMINISTRATION; EXERCISE; FATIGUE; HOSPITALIZATION; HUMAN; METHODOLOGY; MULTIMODALITY CANCER THERAPY; NEOPLASM; PALLIATIVE THERAPY; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; REVIEW; SELF HELP; TERMINALLY ILL PATIENT;

ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; COMBINED MODALITY THERAPY; COUNSELING; DEPRESSION; DIAGNOSIS, DIFFERENTIAL; DRUG ADMINISTRATION SCHEDULE; ERYTHROPOIETIN; EXERCISE; FATIGUE; HUMANS; NEOPLASMS; PALLIATIVE CARE; RANDOMIZED CONTROLLED TRIALS; SELF-HELP GROUPS; SEVERITY OF ILLNESS INDEX; TERMINALLY ILL;

EID: 16644395481     PISSN: 08909091     EISSN: 08909091     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Richardson A: Fatigue in cancer patients: A review of the literature. Eur J Cancer Care 4(1):20-32, 1995.
2. Carr D, Goudas L, Lawrence DP, et al: Management of Cancer Symptoms: Pain, Depression, and Fatigue. Evidence Report/Technology Assessment No. 61. AHRQ Publication No. 02-E032. Rockville, Md; Agency for Healthcare Research and Quality; July 2002.
3. Lawrence DP, Kupelnick B, Miller K, et al: Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr 32:40-50, 2004.
4. King KB, Nail LM, Kreamer K, et al: Patients' descriptions of the experience of receiving radiation therapy. Oncol Nurs Forum 12(4):55-61, 1985.
5. Humy C, Bemhard J, Joss R, et al: "Fatigue and malaise" as a quality-of-life indicator in small-cell lung cancer patients. The Swiss Group for Clinical Cancer Research (SAKK). Support Care Cancer 1:316-320, 1993.
6. Donnelly S, Walsh D, Rybicki L: The symptoms of advanced cancer: Identification of clinical and research priorities by assessment of prevalence and severity. J Palliat Care 11:27-32, 1995.
7. Hickok JT, Morrow GR, McDonald S, et al: Frequency and correlates of fatigue in lung cancer patients receiving radiation therapy: Implications for management. J Pain Symptom Manage 11:370-377, 1996.
8. Longman AJ, Braden CJ, Mishel MH: Side effects burden in women with breast cancer. Cancer Pract 4:274-280, 1996.
9. Richardson A, Ream EK: Self-care behaviours initiated by chemotherapy patients in response to fatigue. Int J Nurs Stud 34:35-43, 1997.
10. Sarna L, Brecht ML: Dimensions of symptom distress in women with advanced lung cancer: A factor analysis. Heart Lung 26:23-30, 1997.
11. Vogelzang NJ, Breitbart W, Cella D, et al: Patient, caregiver, and oncologist perceptions of cancer-related fatigue: Results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 34(3 suppl 2):4-12, 1997.
12. Smets EM, Visser MR, Willems-Groot AF, et al: Fatigue and radiotherapy: (A) Experience in patients undergoing treatment. Br J Cancer 78: 899-906, 1998.
13. Smets EM, Visser MR, Willems-Groot AF, et al: Fatigue and radiotherapy: (B) Experience in patients 9 months following treatment.Br J Cancer 78:907-912, 1998.
14. Gaston-Johansson F, Fall-Dickson JM, Bakos AB, et al: Fatigue, pain, and depression in pre-autotransplant breast cancer patients. Cancer Pract 7:240-247, 1999.
15. Jacobsen PB, Hann DM, Azzarello LM, et al: Fatigue in women receiving adjuvant chemotherapy for breast cancer: Characteristics, course, and correlates. J Pain Symptom Manage 18:233-242, 1999.
16. Loge JH, Abrahamsen AF, Ekeberg O, et al: Hodgkin's disease survivors more fatigued than the general population. J Clin Oncol 17:253-261, 1999.
17. Miaskowski C, Lee KA: Pain, fatigue, and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis: A pilot study. J Pain Symptom Manage 17:320-332, 1999.
18. Monga U, Kerrigan AJ, Thornby J, et al: Prospective study of fatigue in localized prostate cancer patients undergoing radiotherapy. Radiat Oncol Imestig 7:178-185, 1999.
19. Stone P, Hardy J, Broadley K, et al: Fatigue in advanced cancer: A prospective controlled cross-sectional study. Br J Cancer 79:1479-1486, 1999.
20. Bower JE, Ganz PA, Desmond KA, et al: Fatigue in breast cancer survivors: Occurrence, correlates, and impact on quality of life. J Clin Oncol 18:743-753, 2000.
21. Curt GA, Breitbart W, Cella D, et al: Impact of cancer-related fatigue on the lives of patients: New findings from the Fatigue Coalition. Oncologist 5:353-360, 2000.
22. Okuyama T, Akechi T, Kugaya A, et al: Factors correlated with fatigue in disease-free breast cancer patients: Application of the Cancer Fatigue Scale. Support Care Cancer 8:215-222, 2000.
23. Servaes P, van der Werf S, Prins J, et al: Fatigue in disease-free cancer patients compared with fatigue in patients with chronic fatigue syndrome. Support Care Cancer 9:11-17, 2001.
24. Stone P, Hardy J, Huddart R, et al: Fatigue in patients with prostate cancer receiving hormone therapy. Eur J Cancer 36:1134-1141, 2000.
25. Stone P, Richards M, A'Hem R, et al: A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol 11:561-567, 2000.
26. Stone P, Richardson A, Ream E, et al: Cancer-related fatigue: Inevitable, unimportant and unbeatable? Results of a multi-centre patient survey. Ann Oncol 11:971-975, 2000.
27. Cella D, Davis K, Breitbart W, et al: Cancer-related fatigue: Prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 19:3385-3391, 2001.
28. Given CW, Given B, Azzouz F, et al: Predictors of pain and fatigue in the year following diagnosis among elderly cancer patients. J Pain Symptom Manage 21:456-4662001.
29. Okuyama T, Tanaka K, Akechi T, et al: Fatigue in ambulatory patients with advanced lung cancer: Prevalence, correlated factors, and screening. J Pain Symptom Manage 22:554-564, 2001.
30. Wang XS, Janjan NA, Guo H, et al: Fatigue during preoperative chemoradiation for resectable rectal cancer. Cancer 92(6 suppl): 1725-1732, 2001.
31. Nail LM: My get up and go got up and went: Fatigue in people with cancer. J Natl Cancer Inst Monogr 32:72-75, 2004.
32. Mock V, Atkinson A, Barsevick A, et al: NCCN Practice Guidelines for Cancer-Related Fatigue. Oncology 14(11A):151-161, 2000.
33. Mock V: Evidence-based treatment for cancer-related fatigue. J Natl Cancer Inst Monogr 32:112-118, 2004.
34. Berger AM, Farr L: The influence of daytime inactivity and nighttime restlessness on cancer-related fatigue. Oncol Nurs Forum 26:1663-1671, 1999.
35. Barsevick AM, Whitmer K, Sweeney C, et al: A randomized clinical trial of energy conservation for cancer-related fatigue. Cancer 100:1302-1310, 2004.
36. Broeckel JA, Jacobsen PB, Horton J, et al: Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 16:1689-1696, 1998.
37. Redeker NS, Lev EL, Ruggiero J: Insomnia, fatigue, anxiety, depression, and quality of life of cancer patients undergoing chemotherapy. Sch Inq Nurs Pract 14:275-290, 2000.
38. Irvine D, Vincent L, Graydon JE, et al: The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experienced by healthy individuals. Cancer Nurs 17:367-378, 1994.
39. Akechi T, Kugaya A, Okamura H, et al: Fatigue and its associated factors in ambulatory cancer patients: a preliminary study. J Pain Symptom Manage 17:42-48, 1999.
40. Hann DM, Garovoy N, Finkelstein B, et al: Fatigue and quality of life in breast cancer patients undergoing autologous stem cell transplantation: A longitudinal comparative study. J Pain Symptom Manage 17:311-319, 1999.
41. Loge JH, Abrahamsen AF, Ekeberg O, et al: Fatigue and psychiatric morbidity among Hodgkin's disease survivors. J Pain Symptom Manage 19:91-99, 2000.
42. Bruera E, Brenneis C, Michaud M, et al: Association between asthenia and nutritional status, lean body mass, anemia, psychological status, and tumor mass in patients with advanced breast cancer. J Pain Symptom Manage 4:59-63, 1989.
43. Breitbart W, Rosenfeld B, Kaim M, et al: A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease. Arch Intern Med 161:411-420, 2001.
44. Morrow GR, Hickok JT, Roscoe JA, et al: Differential effects of paroxetine on fatigue and depression: A randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol 21:4635-4641, 2003.
45. Seidenfeld J, Piper M, Flamm C, et al: Epoetin treatment of anemia associated with cancer therapy: A systematic review and metaanalysis of controlled clinical trials. J Natl Cancer Inst 93:1204-1214, 2001.
46. Henke M, Laszig R, Rube C, et al: Erythropoietin to treat head and neck cancer patients with anemia undergoing radiotherapy: Randomized, double-blind, placebo-controlled trial. Lancet 362:1255-1260, 2003.
47. Leyland-Jones B: Breast cancer trial with erythropoietin terminated unexpectedly. Lancet Oncol 4:459-460, 2003.
48. Wun T, Law L, Harvey D, et al: Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin. Cancer 98:1514-1520, 2003.
49. Rosenzweig MQ, Bender CM, Lucke JP, et al: The decision to prematurely terminate a trial of R-HuEPO due to thrombotic events. J Pain Symptom Manage 27:185-190, 2004.
50. Rizzo JD, Lichtin AE, Woolf SH, et al: Use of epoetin in patients with cancer: Evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol 20:4083-5107, 2002.
51. Seidenfeld J, Aronson N, Piper MA, et al: Use of Epoetin for Anemia in Oncology. Evidence Report/Technology Assessment No. 30. AHRQ Publication No. 01-E009. Rockville, Md; Agency for Healthcare Research and Quality; June 2001.
52. Demetri GD, Kris M, Wade J, et al: Qual- ity-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study. Procrit Study Group. J Clin Oncol 16:3412-3425, 1998.
53. Glaspy J.'Bukowski R, Steinberg D, et al: Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J Clin Oncol 15:1218-1234, 1997.
54. Gabrilove JL, Cleeland CS, Livingston RB, et al: Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. J Clin Oncol 19:2875-2882, 2001.
55. Littlewood TJ, Bajetta E, Nortier JW, et al: Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 19:2865-2874, 2001.
56. Brower V: Epoetin for cancer patients: A boon or a danger? J Natl Cancer Inst 95:1820-1821, 2003.
57. YasudaY, FujitaY, MatsuoT, et al: Erythropoietin regulates tumor growth of human malignancies. Carcinogenesis 24:1021-1029, 2003.
58. Verhelst D, Rossert J, Casadevall N, et al: Treatment of erythropoietin-induced pure red cell aplasia: a retrospective study. Lancet 363:1768-1771, 2004.